Skip to main content
Neuca S.A. logo

Neuca S.A. — Investor Relations & Filings

Ticker · NEU ISIN · PLTRFRM00018 LEI · 259400KFX90IZ97UDQ91 WAR Wholesale and retail trade
Filings indexed 1,568 across all filing types
Latest filing 2025-05-20 AGM Information
Country PL Poland
Listing WAR NEU

Neuca S.A. is a leader in the wholesale distribution of pharmaceuticals, operating as a comprehensive partner in the healthcare market. The company's core business involves supplying medicines to pharmacies. A key strategic principle is not owning any pharmacies, a conscious decision to avoid competing with its primary clients. Instead, the company focuses on supporting its strategic partners—independent pharmacists—by providing a range of tools and services designed to build their competitiveness and profitability. In addition to its primary distribution activities, the group is also engaged in the manufacturing of pharmaceuticals and the management of clinical trials through its specialized subsidiaries, offering a broad portfolio of services across the healthcare value chain.

Recent filings

Filing Released Lang Actions
zal02_Projekty_uchwal_do_podjecia_na_WZA_2025-06-17.pdf
AGM Information Classification · 99% confidence The document text consists entirely of proposed resolutions ('Projekty uchwał') to be voted upon at a 'Zwyczajne Walne Zgromadzenie' (Annual General Meeting - AGM). Key elements include the date of the meeting (June 17, 2025), resolutions concerning the approval of the 2024 financial statements, dividend decisions, granting of 'absolutorium' (discharge) to management and supervisory board members for their 2024 duties, and changes related to employee incentive programs. This content is characteristic of the formal proceedings and resolutions passed during an AGM. Therefore, the appropriate classification is AGM-R (AGM Information).
2025-05-20 Polish
Zwołanie ZWZA - Content (PL)
AGM Information Classification · 100% confidence The document text is a formal notice in Polish ('Zwołuje... Zwyczajne Walne Zgromadzenie Akcjonariuszy NEUCA S.A.') which translates to 'Summons... the Annual General Meeting of Shareholders of NEUCA S.A.'. It details the date (17 czerwca 2025r.), time, location, and a detailed agenda ('Porządek obrad') covering the approval of annual reports, financial statements, dividend decisions, and board remuneration. This content is characteristic of the official notice calling for an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM Information (AGM-R).
2025-05-20 Polish
Dopuszczenie akcji do obrotu - Content (PL)
Share Issue/Capital Change Classification · 99% confidence The document text, written in Polish, announces that 3,300 ordinary bearer shares (series N) of NEUCA S.A. were admitted and introduced to stock exchange trading on May 16, 2025. It references a prior resolution from the Warsaw Stock Exchange regarding the admission of up to 284,250 shares and the registration process with the National Securities Depository (KDPW). This content directly relates to the issuance, admission, or change in the number of outstanding shares available for public trading. This aligns best with the 'Share Issue/Capital Change' category (SHA), as it details the formal introduction of new shares to the market.
2025-05-16 Polish
Podwyższenie kapitału zakładowego - Content (PL)
Share Issue/Capital Change Classification · 99% confidence The document text explicitly details the registration of 3,300 new shares (akcji serii N) and the resulting increase in the company's share capital (podwyższeniem kapitału zakładowego Spółki). It references resolutions regarding the conditional increase of share capital based on the exercise of subscription warrants. This content directly relates to changes in the company's capital structure through the issuance of new shares, which aligns precisely with the definition of 'Share Issue/Capital Change' (SHA). The document is not a short announcement pointing to another report, but the substantive notification of the capital change itself.
2025-05-16 Polish
zal01_Otrzymanie_darowizny_Entremares_04-2025.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction/transactions referred to in Article 19(1) of the MAR Regulation). It details a transaction involving shares ('akcje') by an entity closely associated with a manager ('Osoba blisko związana z osobami pełniącymi obowiązki zarządcze'). Specifically, it reports the 'Otrzymanie darowizny' (Receipt of a gift/donation) of 5341 shares. This type of filing, reporting personal share transactions by directors or closely associated persons under MAR Article 19, directly corresponds to the definition of Director's Dealing (DIRS). The document length is relatively short (4854 chars), but it is a specific regulatory disclosure, not just an announcement of a report.
2025-04-25 Polish
zal02_Darowizna_akcji_PS_04-2025.pdf
Director's Dealing Classification · 100% confidence The document is titled "Powiadomienie o transakcji/transakcjach*, o którym mowa w art. 19 ust. 1 rozporządzenia MAR" (Notification of a transaction(s) referred to in Article 19(1) of the MAR Regulation). It details a transaction involving a member of management ('Piotr Sucharski', 'Prezes zarządu' - CEO) concerning the company's shares ('akcje'). Specifically, it reports a 'Dokonanie darowizny' (Making a donation) of 5341 shares at a price of 0.00 PLN on 2025-04-04. This structure and content directly correspond to insider trading notifications required under MAR Article 19, which tracks personal share transactions by directors and executives. This matches the definition for Director's Dealing (DIRS).
2025-04-25 Polish

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.